ArticleAntimicrobial agents and chemotherapy2006
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Article
- CAF to the Rescue! Potential and Challenges of Combination Antifungal Therapy for Reducing Morbidity and Mortality in Hospitalized Patients With Serious Fungal Infections.Open forum infectious diseases · 2024Review
- Native Aortic Valve Endocarditis Caused byOpen forum infectious diseases · 2024Article
- Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France.Emerging infectious diseases · 2023Article
- Non-Journal of fungi (Basel, Switzerland) · 2023Review
- Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%).Frontiers in veterinary science · 2021Article
- First reported case of disseminatedIDCases · 2020Article
- Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.International journal of hematology · 2018Article
- Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.Infection · 2017Article
- Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.Antimicrobial agents and chemotherapy · 2016Article
- In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.Antimicrobial agents and chemotherapy · 2015Article
- In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.Antimicrobial agents and chemotherapy · 2015Article
- 21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.Postepy dermatologii i alergologii · 2015Article
- Sinusitis caused by Scopulariopsis brevicaulis: Case report and review of the literature.Medical mycology case reports · 2014Article
- Drug combinations against Mucor irregularis in vitro.Antimicrobial agents and chemotherapy · 2013Article
- Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient.Bone marrow transplantation · 2011Article
- Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.Journal of clinical microbiology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The activities of 10 combinations of antifungal agents against 25 clinical isolates of Scopulariopsis brevicaulis were tested by the checkerboard technique. An average indifferent effect was detected for all combinations. Synergy was observed for some isolates and combinations, particularly with posaconazole-terbinafine (68% of strains), amphotericin B-caspofungin (60%), and posaconazole-caspofungin (48%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.